Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
O teste EndoPredict, da Myriad Genetics, identificou com precisão mulheres na pré-menopausa com câncer de mama ER+, HER2- que poderiam evitar, com segurança, a quimioterapia adjuvante SALT LAKE CITY,...
Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
La prueba EndoPredict de Myriad Genetics identificó con precisión a mujeres premenopáusicas con cáncer de mama ER+, HER2- que podrían evitar la quimioterapia adyuvante de forma segura SALT LAKE CITY,...
Neue Studie, im Clinical Cancer Research Journal veröffentlicht, unterstreicht die Bedeutung des EndoPredict-Tests zur Information über die Behandlung von prämenopausalen Brustkrebs-Patientinnen
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict-Test identifiziert präzise prämenopausale Frauen mit ER+, HER2-Brustkrebs, die eine adjuvante Chemotherapie vermeiden können SALT LAKE CITY, Aug. 31, 2022 (GLOBE...
Une nouvelle étude publiée dans le Clinical Cancer Research Journal met en avant l’utilisation du test EndoPredict pour éclairer les décisions thérapeutiques chez les patientes préménopausées atteintes d’un cancer du sein
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Le test EndoPredict de Myriad Genetics identifie avec précision les femmes préménopausées atteintes d'un cancer du sein RE+, HER2- qui pourraient éviter une chimiothérapie adjuvante sans perte de...
New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 (GLOBE NEWSWIRE)...
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
August 30, 2022 09:37 ET
|
BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
Questco Partners with Espyr to Offer Small Businesses Mental Health Benefits and More
August 29, 2022 10:15 ET
|
Espyr
HOUSTON, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Questco, a leading outsourced HR service provider, announced today a partnership with Espyr, a leader in workplace mental health and well-being programs,...
The California Food is Medicine Coalition Announces New Director to Advance Medically Tailored Nutrition in California
August 29, 2022 10:00 ET
|
CalFIMC
SAN FRANCISCO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The California Food is Medicine Coalition (CalFIMC), an association of leading nutrition services providers in the state, named Michelle Kuppich the...
Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health
August 29, 2022 08:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Rythmia Life Advancement Center Praises Pro Athletes' Statements on the Benefits of Psychedelics
August 29, 2022 08:02 ET
|
Rythmia Life Advancement Center
LOS ANGELES, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Green Bay Packers quarterback Aaron Rodgers and several other prominent professional athletes are speaking publicly about the benefits of psychedelics...